Medicine
Megestrol 125 mg/mL oral suspension
Megestrol 125 mg/mL oral suspension is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store megestrol acetate oral suspension between 20° to 25° C (68° to 77° F)…
Key facts
- Active ingredient (INN)
- Megestrol
- Brand
- Sold under the generic name
- Strength
- 125 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 150 mL, 35 mL
- Manufacturers
- Upsher-Smith LaboratoriesProficient Rx
- Origin register
- US FDA, United States
- Storage
- Store megestrol acetate oral suspension between 20° to 25° C (68° to 77° F) and dispense in a tight container. Protect from heat.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02AB01 Megestrol
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2015
- Identifiers
- RxCUI 577154DailyMed set ID 2dc921d5-e423-4379-a345-151e87d13651, 6342df31-afce-4deb-b992-e08e2a4b2b77NDC 24979-041, 71205-943Application ANDA203139
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 150 mL in 1 bottle | 24979-041-13 | Upsher-Smith Laboratories | 28 July 2015 |
| 35 mL in 1 bottle | 24979-041-35 | Upsher-Smith Laboratories | 1 December 2025 |
| 150 mL in 1 bottle | 71205-943-15 | Proficient Rx | 19 November 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 August 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Megestrol
Clinical summary
Megestrol is a progestin indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). It is available as oral suspension and tablets. MedsAcross supplies Megestrol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MegestrolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Megestrol Acetate prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Megestrol 125 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.